Just when planning for the end of a product’s patent life seemed to be getting easier, Congress is changing the rules again. Legislation signed by the President February 8 significantly changes the economics of "authorized" generics, an increasingly popular approach used by manufacturers seeking to maximize their revenue streams from off-patent products.
The new law will require brand companies to include the "authorized" generic in their pricing calculations they use to determine...